Delivery Order SPE2DB24D2100-SPE2DB25FBFNU
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,357.35 by the Defense Logistics Agency (DLA) for Shingrix vial kits, with an ultimate completion date of August 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader federal contracting relationship with DLA. This award falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits valued at $8,769.12, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,417.54 to AmerisourceBergen Drug Corp for Shingrix vial kits on July 28, 2025, with completion expected by July 29, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. Shingrix is a recombinant zoster vaccine used...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits with a ceiling value of $1,139.18. This firm fixed-price contract, which was competitively awarded without a set-aside designation, has an ultimate completion date of August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine commonly procured for military and veteran healthcare systems to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,391.80 by the Defense Logistics Agency on July 21, 2025, for the supply of Shingrix vial kits. This firm fixed-price contract represents a non-set-aside competitive award with an ultimate completion date of July 22, 2025. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide SHINGRIX vial kits. The contract has a potential value of $1,104.08 and a completion date of February 2, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.18 to AmerisourceBergen Drug Corp for Shingrix vial kits on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,779.14 to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion date of July 22, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's corporate office...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at approximately $30.4K to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of August 8, 2025. This competitive, firm fixed-price delivery order was issued on August 7, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine indicated for the prevention of herpes zoster and its...
- Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,563,775,114 SHINGRIX vial kits. The contract has a potential value of $16,075.81 and a completion date of February 27, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFNUDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) for Shingrix vial kits, with a ceiling value of $1,139.18. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 1, 2025. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine indicated for prevention of herpes zoster (shingles) in adults, representing a critical pharmaceutical supply for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements through open competition, positioning it as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/31/25 |